IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

BXP, Inc. (BXP)

Business Summary

BXP, Inc. is a fully integrated, self-administered and self-managed real estate investment trust (REIT) and one of the largest publicly-traded office REITs (based on total market capitalization as of December 31, 2025) in the United States that develops, owns and manages primarily premier workplaces. The company's properties are concentrated in six dynamic gateway markets: Boston, Los Angeles, New York, San Francisco, Seattle and Washington, DC. At December 31, 2025, BXP owned or had joint venture interests in a portfolio of 179 commercial real estate properties, aggregating approximately 52.6 million net rentable square feet of primarily premier workplaces, including eight properties under construction/redevelopment totaling approximately 3.5 million net rentable square feet. The properties consisted of 157 office properties (including four properties under construction/redevelopment), 14 retail properties (including one property under construction), seven residential properties (including three properties under construction), and one hotel.

BXP competes in the leasing of premier workplace, retail and residential space with a considerable number of other real estate companies, some of which may have greater financial resources. The company's competitive advantages include its development experience, organizational depth, utilization of joint venture partner relationships, and balance sheet position, which allow it to selectively develop premier workplaces. Additional competitive factors include control of sites that could support approximately 13.6 million and 4.7 million of additional square feet of new office and residential developments, respectively, a reputation gained through 56 years of successful operations, relationships with leading national corporations, universities and public institutions, relationships with nationally recognized financial institutions, a track record for executing acquisitions efficiently, ability to act quickly on due diligence and financing, relationships with institutional buyers and sellers, ability to procure entitlements from multiple municipalities, and relationships with domestic and foreign investors.

BXP generates revenue primarily through the ownership, management, and leasing of premier workplaces, including office, retail, residential, and hotel properties. The company is a full-service real estate company with substantial in-house expertise in acquisitions, development, financing, capital markets, construction management, property management, marketing, leasing, accounting, risk management, tax and legal services. BXP refers to its tenants as 'clients' due to the many facets of continuous engagements that span beyond the usual tenant/landlord relationship. The company's business is conducted through Boston Properties Limited Partnership (BPLP), an umbrella partnership REIT (UPREIT) structure, with BXP as the sole general partner. As of December 31, 2025, BXP owned an approximate 89.7% ownership interest in BPLP, with the remaining approximate 10.3% interest owned by limited partners.

BXP's portfolio at December 31, 2025, consisted of 157 office properties (including four properties under construction/redevelopment), 14 retail properties (including one property under construction), seven residential properties (including three properties under construction), and one hotel. The weighted-average lease term of in-place leases based on square feet, including leases signed by unconsolidated joint ventures, was approximately 7.9 years. In 2025, BXP executed approximately 5.6 million square feet of leases with a weighted-average lease term of 10.1 years. Based on leases in place at December 31, 2025, leases with respect to approximately 2.6% , or approximately 1.2 million square feet, of the total square feet in the portfolio, including unconsolidated joint ventures but excluding Gateway Commons and North First Business Park, will expire in calendar year 2026. The total development pipeline, including office, laboratory/life sciences and retail developments, but excluding residential developments, was 61% pre-leased as of February 20, 2026.

During the year ended December 31, 2025, BXP acquired 2100 M Street, a vacant office building in Washington, DC, for a purchase price, including transaction costs, of approximately $55.9 million of cash. Excluding unconsolidated joint ventures, BXP completed eight sale transactions for an aggregate gross sales price of approximately $702.6 million , resulting in net proceeds of approximately $682.5 million and gains on sales of real estate of $175.0 million and $177.6 million for BXP and BPLP, respectively. BXP recognized impairment losses of approximately $85.8 million and $82.9 million for BXP and BPLP, respectively. BXP commenced development/redevelopment of four properties, including 343 Madison Avenue in New York City, aggregating approximately 1.9 million in estimated net rentable square feet when complete, with the company's share of the aggregated estimated total investment to complete these properties being approximately $2.1 billion . BXP also partially or fully placed in-service four properties that totaled approximately 727,000 net rentable square feet. As of December 31, 2025, BXP had eight properties under construction/redevelopment, aggregating approximately 3.5 million in estimated net rentable square feet when completed, with an estimated share of the aggregate total investment to complete these projects of approximately $3.9 billion , of which approximately $2.5 billion remained to be invested. BXP acquired its partner's 45% ownership interest in the consolidated entity developing 343 Madison Avenue for approximately $43.5 million of cash. BXP acquired an aggregate of 291,040 common units of limited partnership interest, including a total of 87,398 common units issued upon the conversion of LTIP Units, 2012 OPP Units and 2013-2021 MYLTIP awards, presented by the holders for redemption, in exchange for an equal number of shares of BXP common stock. BXP's unconsolidated joint ventures completed three sale transactions, with BXP's share of the aggregate gross sales price being approximately $237.7 million , resulting in BXP's share of net proceeds of approximately $170.2 million and recognized gains on sales of approximately $53.7 million . BXP recognized an other-than-temporary impairment loss on its investment in Gateway Commons of approximately $145.1 million . In the aggregate, excluding unconsolidated joint ventures, BXP's debt market activities totaled approximately $4.2 billion . BXP repaid $850.0 million of 3.20% unsecured senior notes due January 15, 2025, upsized the unsecured commercial paper program from $500.0 million to $750.0 million in March 2025, extended the maturity date for the $700.0 million unsecured term loan to 2030, upsized the amended and restated revolving credit agreement from $2.0 billion to $2.25 billion and extended its maturity date to 2030 in March 2025, and issued $1.0 billion of 2.00% unsecured exchangeable senior notes due 2030 in September 2025. BPLP entered into an interest rate swap contract with a notional amount of $300.0 million to fix Daily Simple SOFR at a fixed interest rate of 3.6775% per annum. BXP's unconsolidated joint ventures' debt market activities totaled approximately $1.2 billion , of which BXP's share was approximately $0.5 billion .

Business Outlook & Financial Sufficiency

At BXP's September 2025 Investor Day, management detailed a three-year action plan focused on near-term earnings growth by leveraging BXP's operational expertise and portfolio of premier workplaces within core gateway markets to: grow occupancy; develop premier assets with a focus on projects underway and a selective approach to future opportunities; execute on a multi-year asset sales program to dispose of non-income producing land, select residential, and non-strategic and select strategic office assets, with proceeds designated to reduce leverage and fund the development pipeline; and secure private equity partnerships on select assets to complement other funding sources and increase investment yields.

A key component of BXP's strategic action plan is the execution of a multi-year asset sales program to generate approximately $1.9 billion in net proceeds to fund the development pipeline and reduce leverage. BXP also intends to pursue external growth through selective development of premier workplaces, including high-rise urban developments, mixed-use developments (including office, residential and retail), low-rise suburban office and residential properties, within budget and on schedule. The company believes it is well-positioned to achieve external growth through acquisitions and may explore joint venture or lending opportunities with existing property owners located in desirable locations. BXP also intends to seek third-party development contracts to enable it to retain and utilize existing development and construction management staff, especially when internal development is less active or when new development is less-warranted due to market conditions.

BXP's internal growth strategies focus on increasing cash flow from existing properties through an increase in occupancy and rental rates, as the properties are of high quality and in desirable locations with diversified economies that have historically experienced job growth. The strategy includes providing high-quality property management services using employees to encourage clients to renew, expand and relocate; achieving speed and transaction cost efficiency in replacing departing clients through in-house services; and working with new or existing clients with space expansion or contraction needs, leveraging expertise and clustering of assets to maximize cash flow. BXP also expects to benefit from the re-development of existing assets, where increasing building size and/or cash flow can generate appropriate returns on incremental investment.

BXP's capital allocation strategy includes a multi-year asset sales program to generate approximately $1.9 billion in net proceeds to fund the development pipeline and reduce leverage. The company also plans to secure private equity partnerships on select assets to complement other funding sources and increase investment yields. BXP's debt market activities in 2025 totaled approximately $4.2 billion , underscoring consistent access to debt capital. The company upsized its unsecured commercial paper program from $500.0 million to $750.0 million and upsized its revolving credit agreement from $2.0 billion to $2.25 billion with a maturity date extended to 2030. BXP also issued $1.0 billion of 2.00% unsecured exchangeable senior notes due 2030.

BXP's development pipeline as of December 31, 2025, included eight properties under construction/redevelopment, aggregating approximately 3.5 million in estimated net rentable square feet when completed. The company estimates its share of the aggregate estimated total investment to complete these projects is approximately $3.9 billion , of which approximately $2.5 billion remained to be invested as of December 31, 2025. The total development pipeline, including office, laboratory/life sciences and retail developments, but excluding residential developments, was 61% pre-leased as of February 20, 2026. BXP's unconsolidated joint ventures' debt market activities totaled approximately $1.2 billion , of which BXP's share was approximately $0.5 billion .

BXP's capital allocation also includes the 2025 Multi-Year Long-Term Incentive Program awards approved on January 22, 2025, with an aggregate value of approximately $12.7 million , and the 2025 Outperformance Plan Awards approved on December 22, 2025, with an aggregate value of approximately $31.9 million for an opportunity to earn up to an aggregate of 711,864 LTIP Units. BXP also acquired an aggregate of 291,040 common units of limited partnership interest in exchange for an equal number of shares of BXP common stock during 2025.

Management Sentiments & Priorities

Management's message to shareholders, as detailed at the September 2025 Investor Day, emphasizes a three-year action plan focused on near-term earnings growth by leveraging BXP's operational expertise and portfolio of premier workplaces within core gateway markets. The strategic priorities emphasized for the period ahead include: growing occupancy; developing premier assets with a focus on projects underway and a selective approach to future opportunities; executing on a multi-year asset sales program to generate approximately $1.9 billion in net proceeds to dispose of non-income producing land, select residential, and non-strategic and select strategic office assets, with proceeds designated to reduce leverage and fund the development pipeline; and securing private equity partnerships on select assets to complement other funding sources and increase investment yields. Management believes these components align with the broader, long-term strategy of maintaining leadership in core markets, prudently growing the portfolio, and disciplined capital allocation to drive shareholder value.

Financial Details

For the fiscal year ended December 31, 2025, BXP reported total revenues of $3,283,088,000 compared to $3,268,178,000 for the fiscal year ended December 31, 2024. Net income attributable to BXP, Inc. was $1,003,575,000 for 2025 compared to $1,014,993,000 for 2024. Diluted earnings per share (EPS) for BXP, Inc. was $6.33 for 2025 compared to $6.40 for 2024. Operating income was $1,070,807,000 for 2025 compared to $1,118,575,000 for 2024. Net income attributable to BXP, Inc. included gains on sales of real estate of $175,044,000 and impairment losses of $85,832,000 . For BPLP, net income was $1,103,148,000 for 2025 compared to $1,107,676,000 for 2024, with gains on sales of real estate of $177,555,000 and impairment losses of $82,945,000 . Funds from Operations (FFO) attributable to BXP, Inc. was $1,571,396,000 for 2025 compared to $1,573,285,000 for 2024. BXP's share of total revenues from unconsolidated joint ventures was $1,019,000,000 for 2025 compared to $1,009,000,000 for 2024. As of December 31, 2025, BXP had cash and cash equivalents of $1,082,676,000 and total consolidated debt of $11,625,000,000 .

Risk Factors

BXP's performance depends upon the economic conditions, particularly the supply and demand characteristics, of its six gateway markets: Boston, Los Angeles, New York, San Francisco, Seattle and Washington, DC. Market and economic volatility due to adverse economic and political conditions, health crises or dislocations in the credit markets could have a material adverse effect on results of operations, financial condition and ability to pay dividends and/or distributions. The company faces risks associated with sustained changes in client preferences and space utilization from full-time, collective in-person work environments to hybrid or remote work models and/or changes from workforce reduction due to artificial intelligence, which could decrease overall demand for workplaces and negatively impact market rental rates and property values. BXP's maturing debt bears interest at lower rates than current market rates, which has increased, and may continue to increase interest costs and could adversely impact the ability to refinance existing debt or sell assets on favorable terms or at all. The company's degree of leverage could limit its ability to obtain additional financing or affect the market price of its equity and debt securities. BXP also faces risks associated with climate change and severe weather events, as well as regulatory efforts intended to reduce the effects of climate change, and potential liability for environmental contamination could result in substantial costs.

References

  1. [1] Item 1, Business — General
  2. [2] Item 1, Business — General
  3. [3] Item 1, Business — General
  4. [4] Item 1, Business — General
  5. [5] Item 1, Business — General
  6. [6] Item 1, Business — General
  7. [7] Item 1, Business — General
  8. [8] Item 1, Business — Growth Strategies
  9. [9] Item 1, Business — Growth Strategies
  10. [10] Item 1, Business — Growth Strategies
  11. [11] Explanatory Note
  12. [12] Explanatory Note
  13. [13] Item 1, Business — General
  14. [14] Item 1, Business — General
  15. [15] Item 1, Business — General
  16. [16] Item 1, Business — General
  17. [17] Item 1, Business — Internal Growth Strategies
  18. [18] Item 1, Business — Internal Growth Strategies
  19. [19] Item 1, Business — Internal Growth Strategies
  20. [20] Item 1, Business — Internal Growth Strategies
  21. [21] Item 1, Business — Internal Growth Strategies
  22. [22] Item 1, Business — Transactions During 2025
  23. [23] Item 1, Business — Transactions During 2025, Acquisitions
  24. [24] Item 1, Business — Transactions During 2025, Dispositions and Impairments
  25. [25] Item 1, Business — Transactions During 2025, Dispositions and Impairments
  26. [26] Item 1, Business — Transactions During 2025, Dispositions and Impairments
  27. [27] Item 1, Business — Transactions During 2025, Dispositions and Impairments
  28. [28] Item 1, Business — Transactions During 2025, Dispositions and Impairments
  29. [29] Item 1, Business — Transactions During 2025, Dispositions and Impairments
  30. [30] Item 1, Business — Transactions During 2025, Dispositions and Impairments
  31. [31] Item 1, Business — Transactions During 2025, Developments/Redevelopments
  32. [32] Item 1, Business — Transactions During 2025, Developments/Redevelopments
  33. [33] Item 1, Business — Transactions During 2025, Developments/Redevelopments
  34. [34] Item 1, Business — Transactions During 2025, Developments/Redevelopments
  35. [35] Item 1, Business — Transactions During 2025, Developments/Redevelopments
  36. [36] Item 1, Business — Transactions During 2025, Developments/Redevelopments
  37. [37] Item 1, Business — Transactions During 2025, Developments/Redevelopments
  38. [38] Item 1, Business — Transactions During 2025, Developments/Redevelopments
  39. [39] Item 1, Business — Transactions During 2025, Developments/Redevelopments
  40. [40] Item 1, Business — Transactions During 2025, Noncontrolling Interest
  41. [41] Item 1, Business — Transactions During 2025, Noncontrolling Interest
  42. [42] Item 1, Business — Transactions During 2025, Equity Transactions
  43. [43] Item 1, Business — Transactions During 2025, Equity Transactions
  44. [44] Item 1, Business — Transactions During 2025, Investments in Unconsolidated Joint Ventures
  45. [45] Item 1, Business — Transactions During 2025, Investments in Unconsolidated Joint Ventures
  46. [46] Item 1, Business — Transactions During 2025, Investments in Unconsolidated Joint Ventures
  47. [47] Item 1, Business — Transactions During 2025, Investments in Unconsolidated Joint Ventures
  48. [48] Item 1, Business — Transactions During 2025, Investments in Unconsolidated Joint Ventures
  49. [49] Item 1, Business — Transactions During 2025, Debt
  50. [50] Item 1, Business — Transactions During 2025, Debt
  51. [51] Item 1, Business — Transactions During 2025, Debt
  52. [52] Item 1, Business — Transactions During 2025, Debt
  53. [53] Item 1, Business — Transactions During 2025, Debt
  54. [54] Item 1, Business — Transactions During 2025, Debt
  55. [55] Item 1, Business — Transactions During 2025, Debt
  56. [56] Item 1, Business — Transactions During 2025, Debt
  57. [57] Item 1, Business — Transactions During 2025, Hedging Transaction
  58. [58] Item 1, Business — Transactions During 2025, Hedging Transaction
  59. [59] Item 1, Business — Transactions During 2025, Investments in Unconsolidated Joint Ventures
  60. [60] Item 1, Business — Transactions During 2025, Investments in Unconsolidated Joint Ventures
  61. [61] Item 1, Business — Dispositions
  62. [62] Item 1, Business — Dispositions
  63. [63] Item 1, Business — Transactions During 2025, Debt
  64. [64] Item 1, Business — Transactions During 2025, Debt
  65. [65] Item 1, Business — Transactions During 2025, Debt
  66. [66] Item 1, Business — Transactions During 2025, Debt
  67. [67] Item 1, Business — Transactions During 2025, Debt
  68. [68] Item 1, Business — Transactions During 2025, Debt
  69. [69] Item 1, Business — Transactions During 2025, Developments/Redevelopments
  70. [70] Item 1, Business — Transactions During 2025, Developments/Redevelopments
  71. [71] Item 1, Business — Transactions During 2025, Developments/Redevelopments
  72. [72] Item 1, Business — Transactions During 2025, Developments/Redevelopments
  73. [73] Item 1, Business — Transactions During 2025, Developments/Redevelopments
  74. [74] Item 1, Business — Transactions During 2025, Investments in Unconsolidated Joint Ventures
  75. [75] Item 1, Business — Transactions During 2025, Investments in Unconsolidated Joint Ventures
  76. [76] Item 1, Business — Transactions During 2025, Stock Option and Incentive Plan
  77. [77] Item 1, Business — Transactions During 2025, Stock Option and Incentive Plan
  78. [78] Item 1, Business — Transactions During 2025, Stock Option and Incentive Plan
  79. [79] Item 1, Business — Transactions During 2025, Equity Transactions
  80. [80] Item 1, Business — Dispositions
  81. [81] Item 8, Financial Statements — Consolidated Statements of Operations
  82. [82] Item 8, Financial Statements — Consolidated Statements of Operations
  83. [83] Item 8, Financial Statements — Consolidated Statements of Operations
  84. [84] Item 8, Financial Statements — Consolidated Statements of Operations
  85. [85] Item 8, Financial Statements — Consolidated Statements of Operations
  86. [86] Item 8, Financial Statements — Consolidated Statements of Operations
  87. [87] Item 8, Financial Statements — Consolidated Statements of Operations
  88. [88] Item 8, Financial Statements — Consolidated Statements of Operations
  89. [89] Item 8, Financial Statements — Consolidated Statements of Operations
  90. [90] Item 8, Financial Statements — Consolidated Statements of Operations
  91. [91] Item 8, Financial Statements — Consolidated Statements of Operations
  92. [92] Item 8, Financial Statements — Consolidated Statements of Operations
  93. [93] Item 8, Financial Statements — Consolidated Statements of Operations
  94. [94] Item 8, Financial Statements — Consolidated Statements of Operations
  95. [95] Item 7, MD&A — Funds from Operations
  96. [96] Item 7, MD&A — Funds from Operations
  97. [97] Item 7, MD&A — Results of Operations
  98. [98] Item 7, MD&A — Results of Operations
  99. [99] Item 8, Financial Statements — Consolidated Balance Sheets
  100. [100] Item 8, Financial Statements — Consolidated Balance Sheets

Analysis on 6/21/2026